Nancy M. Schlichting, a director at Encompass Health Corp, has filed a report detailing a transaction involving restricted stock units (RSUs) associated with dividend payments. This transaction, filed on October 19, 2026, is significant as it underscores the company's strategy to align executive compensation with shareholder interests.
Encompass Health Corp, a prominent player in the healthcare services sector, focuses on rehabilitation and post-acute care services. The company, which trades under the ticker symbol EHC, has a history of rewarding its directors and executives through equity compensation, a practice that is becoming increasingly common in the industry.
Background
Encompass Health Corp operates within the services-hospitals sector, specifically categorized under the SIC code 8060. The company is incorporated in Delaware and has its headquarters in Birmingham, Alabama. Encompass Health has undergone several name changes in its history, previously known as HealthSouth Corp and HealthSouth Rehabilitation Corp.
What the Filing Says
According to the recent filing, Schlichting reported a transaction dated October 15, 2026, where she acquired 38 shares of Encompass Health common stock. This acquisition was part of the RSUs credited to her account due to a dividend payment made by the company. The filing notes, "On October 15, 2026, Encompass Health paid a dividend on its common stock of $0.21 per share... The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment." Following this transaction, Schlichting owns a total of 23,010 shares.
Impact
This transaction may influence both the company's governance and its shareholders. By rewarding directors like Schlichting with RSUs, Encompass Health aims to ensure that its leadership remains motivated and aligned with the interests of shareholders. This approach can foster a culture of accountability and performance within the company.
What's Next
The filing does not say what happens next.